| Yazarlar |
Serap Şimşek-Yavuz
Türkiye |
|
Ahmet Rüçhan Akar
Türkiye |
|
Sinan Aydoğdu
Türkiye |
|
Denef Berzeg-Deniz
|
|
Hakan Demir
Türkiye |
|
Tuncay Hazırolan
Türkiye |
|
Mehmet Ali Özatik
Türkiye |
|
Necla Özer
Türkiye |
|
Murat Sarğın
Türkiye |
|
Emine Nursen Topcuoğlu
Türkiye |
|
Nesrin Turhan
Türkiye |
|
Mehmet Birhan Yılmaz
Türkiye |
|
Özlem Azap
Başkent Üniversitesi, Türkiye |
|
Seniha Başaran
Türkiye |
|
Yasemin Çağ
Türkiye |
|
Arif Atahan Çağatay
Türkiye |
|
Güle Çınar
Türkiye |
|
Sibel Doğan Kaya
|
Dr. Öğr. Üyesi Lokman HİZMALİ
Türkiye |
|
Mehmet Emirhan Işık
Türkiye |
|
Nirgül Kılıçaslan
|
|
Şirin Menekşe
Türkiye |
|
Meliha Meriç Koç
Türkiye |
|
Serpil Öztürk
Türkiye |
|
Ayfer Şensoy
|
|
Ayşe Yasemin Tezer Tekçe
Sağlık Bilimleri Üniversitesi, Türkiye |
|
Elif Tükenmez Tigen
|
|
Yeşim Uygun Kızmaz
Türkiye |
|
Mutlu Şeyda Velioğlu Ölmez
|
|
Ayşegül Yeşilkaya
Türkiye |
|
Emel Yılmaz
Türkiye |
|
Neziha Yılmaz
Türkiye |
|
Fatma Yılmaz Karadağ
Türkiye |
| Özet |
| Infective endocarditis (IE) is rare, but associated with significant morbidity and mortality rates. Estimates of the incidence of IE in Turkey are compromised by the absence of population-based prospective studies. Due to the frequent presence of predisposing cardiac conditions and higher rates of nosocomial bacteremia in high-risk groups, the incidence of IE is expected to be higher in Turkey. Additionally, while IE generally affects older people in developed countries, it still affects young people in Turkey. In order to reduce the mortality and morbidity, it is critical to diagnose the IE to determine the causative agent and to start treatment rapidly. However, most of the patients cannot be diagnosed in their first visits, about half of them can be diagnosed after three months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of identification of causative organisms is significantly lower in Turkey than in developed countries. Furthermore, most of the centers do not perform some essential microbiological diagnostic tests as a routine practice. Some antimicrobials that are recommended as the first-line of treatment for IE, particularly antistaphylococcal penicillins, are not available in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. Physicians can follow patients with IE in many specialties. Diagnosis and treatment processes of IE should be standardized at every stage so that management of IE, a setting in which many physicians are involved, can always be in line with current recommendations. Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases has called for collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the light of current information and local data in Turkey. |
| Anahtar Kelimeler |
| Diagnosis | endocarditis | prevention | treatment |
| Makale Türü | Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) |
| Makale Alt Türü | SCI, SSCI, AHCI, SCI-Exp dergilerinde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale |
| Dergi Adı | TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY |
| Dergi ISSN | 1301-5680 |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Makale Dili | İngilizce |
| Basım Tarihi | 01-2020 |
| Cilt No | 28 |
| Sayı | 1 |
| Sayfalar | 2 / 42 |
| Doi Numarası | 10.5606/tgkdc.dergisi.2020.01954 |
| Atıf Sayıları | |
| WoS | 3 |
